News
- Category: Publications
- The Unity trial presented at the ANRS MIE 2025 Scientific Days
- Lessons learned from MOSAIC, the European cohort of human mpox
- Treating mpox in Africa: MOSA begins Patient enrollment in DRC
- Tecovirimat for the treatment of mpox: UNITY investigators announce trial will continue as planned, with top-line results expected mid-2025
- The story of MPX-RESPONSE in Horizon magazine
- EPOXI trial is on, with the inclusion of its first participants
- First consortium annual meeting in Madrid, June 2024
- EPOXI trial Receives Authorization to Begin Enrolling Patients
- Advancing understanding on mpox clade 2: First MOSAIC results presented at CROI 2023 conference